Who owns Atara Biotherapeutics?
- CUSIP Number: 046513107
Tip: Access positions for across all investors
Analyze quarterly positions in Atara Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atara Biotherapeutics stock
Who bought or sold Atara Biotherapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| IFP Advisors | 4.5k | $1.8k | 0% | Jun 2024 |
|
| EverSource Wealth Advisors | 35.00 | $285.001500 | 0% | Sep 2024 |
|
Who sold out of Atara Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| EcoR1 Capital | Mar 2024 | 10M | $7.1M |
| BlackRock | Mar 2024 | 6.8M | $4.7M |
| Vanguard Group | Mar 2024 | 5.0M | $3.5M |
| State Street Corporation | Mar 2024 | 2.5M | $1.7M |
| Morgan Stanley | Mar 2024 | 1.3M | $934k |
| J. Goldman & Co | Mar 2024 | 987k | $685k |
| Checkpoint Capital | Mar 2024 | 893k | $620k |
| Northern Trust | Mar 2024 | 851k | $591k |
| Shay Capital | Mar 2024 | 439k | $304k |
| Manufacturers Life Insurance Company | Mar 2024 | 312k | $217k |
| Goldman Sachs Group | Mar 2024 | 244k | $170k |
| Alliancebernstein | Mar 2024 | 167k | $116k |
| Boxer Capital | Jun 2024 | 166k | $1.4M |
| ProShare Advisors | Mar 2024 | 17k | $12k |
| Advisor Group Holdings | Mar 2024 | 17k | $12k |
| Neuberger Berman Group | Mar 2024 | 12k | $8.3k |
| Hsbc Holdings | Mar 2024 | 11k | $7.8k |
| Lake Street Advisors Group | Jun 2024 | 11k | $94k |
| Tower Research Capital | Mar 2024 | 5.9k | $4.1k |
| CWM | Jun 2024 | 542.00 | $5.0k |